Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,977.30
+5.60 (0.28%)
Sep 29, 2025, 10:30 AM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 556.42 billion as of September 26, 2025. Its market cap has increased by 14.12% in one year.
Market Cap
556.42B
Enterprise Value
564.09B
Revenue
134.56B
Ranking
n/a
PE Ratio
73.85
Stock Price
1,977.30
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 556.42B, an increase of 48,313.28%. That is a compound annual growth rate of 28.94%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.02B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,211.15B |
| Apollo Hospitals Enterprise | 1,079.82B |
| Mankind Pharma | 1,024.84B |
| Zydus Lifesciences | 981.08B |
| Fortis Healthcare | 704.19B |
| Alkem Laboratories | 649.60B |